nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—adrenal gland cancer	0.966	1	CbGaD
Bismuth Subsalicylate—TF—urine—adrenal gland cancer	0.00886	0.53	CbGeAlD
Bismuth Subsalicylate—TF—gonad—adrenal gland cancer	0.00194	0.116	CbGeAlD
Bismuth Subsalicylate—TF—adrenal gland—adrenal gland cancer	0.00169	0.101	CbGeAlD
Bismuth Subsalicylate—TF—EPHB forward signaling—CDC42—adrenal gland cancer	0.0014	0.0814	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—SPARC—adrenal gland cancer	0.0011	0.064	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.00105	0.061	CbGpPWpGaD
Bismuth Subsalicylate—ALB—adrenal gland—adrenal gland cancer	0.000881	0.0528	CbGeAlD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.00086	0.0501	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—IGF2—adrenal gland cancer	0.000758	0.0442	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000736	0.0429	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.000722	0.0421	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—adrenal cortex—adrenal gland cancer	0.000665	0.0398	CbGeAlD
Bismuth Subsalicylate—PTGS1—cardiac atrium—adrenal gland cancer	0.000575	0.0345	CbGeAlD
Bismuth Subsalicylate—PTGS1—pituitary gland—adrenal gland cancer	0.000562	0.0337	CbGeAlD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000544	0.0317	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—pituitary gland—adrenal gland cancer	0.000537	0.0322	CbGeAlD
Bismuth Subsalicylate—PTGS1—adrenal gland—adrenal gland cancer	0.000502	0.0301	CbGeAlD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.000487	0.0284	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—adrenal gland—adrenal gland cancer	0.00048	0.0287	CbGeAlD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—PRKACA—adrenal gland cancer	0.00047	0.0274	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.000462	0.0269	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.000362	0.0211	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000349	0.0203	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	0.000342	0.0199	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000336	0.0196	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.0003	0.0175	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—SPARC—adrenal gland cancer	0.000251	0.0146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.000251	0.0146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.000246	0.0143	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—PRKACA—adrenal gland cancer	0.000212	0.0123	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000212	0.0123	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000206	0.012	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—SPARC—adrenal gland cancer	0.0002	0.0117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000191	0.0111	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.000191	0.0111	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000184	0.0107	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—CDC42—adrenal gland cancer	0.00018	0.0105	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IGF2—adrenal gland cancer	0.000173	0.0101	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000172	0.01	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—GNAS—adrenal gland cancer	0.000172	0.01	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000167	0.00971	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000149	0.00866	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000146	0.00853	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000146	0.0085	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—IGF2—adrenal gland cancer	0.000138	0.00804	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.000132	0.00766	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00013	0.00756	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000118	0.00689	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000106	0.00618	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000105	0.0061	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.0001	0.00584	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	9.35e-05	0.00544	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	8.88e-05	0.00517	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	8.28e-05	0.00482	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—RB1—adrenal gland cancer	8.1e-05	0.00472	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—POMC—adrenal gland cancer	7.78e-05	0.00453	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	7.51e-05	0.00437	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SDHB—adrenal gland cancer	6.96e-05	0.00405	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	6.81e-05	0.00397	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	6.36e-05	0.0037	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	6.16e-05	0.00359	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	6.13e-05	0.00357	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.96e-05	0.00347	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SH3KBP1—adrenal gland cancer	5.61e-05	0.00327	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SDHB—adrenal gland cancer	5.52e-05	0.00322	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—adrenal gland cancer	5.49e-05	0.0032	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.48e-05	0.00319	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ZNRF3—adrenal gland cancer	5.27e-05	0.00307	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—adrenal gland cancer	5.11e-05	0.00297	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.82e-05	0.00281	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—EGFR—adrenal gland cancer	4.72e-05	0.00275	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SPARC—adrenal gland cancer	4.58e-05	0.00267	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SDHD—adrenal gland cancer	4.48e-05	0.00261	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—RRM1—adrenal gland cancer	4.48e-05	0.00261	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SDHB—adrenal gland cancer	4.47e-05	0.0026	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.35e-05	0.00253	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.05e-05	0.00236	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—adrenal gland cancer	3.96e-05	0.00231	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PRKACA—adrenal gland cancer	3.86e-05	0.00225	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—RRM1—adrenal gland cancer	3.56e-05	0.00207	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SDHD—adrenal gland cancer	3.56e-05	0.00207	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.52e-05	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.34e-05	0.00195	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MED12—adrenal gland cancer	3.34e-05	0.00195	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SPRY2—adrenal gland cancer	3.31e-05	0.00192	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CDC42—adrenal gland cancer	3.28e-05	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.21e-05	0.00187	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF2—adrenal gland cancer	3.16e-05	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GNAS—adrenal gland cancer	3.13e-05	0.00182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MEN1—adrenal gland cancer	3.03e-05	0.00176	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.99e-05	0.00174	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RRM1—adrenal gland cancer	2.88e-05	0.00168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SDHD—adrenal gland cancer	2.88e-05	0.00168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.71e-05	0.00158	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.7e-05	0.00157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.66e-05	0.00155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MED12—adrenal gland cancer	2.65e-05	0.00155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PRKACA—adrenal gland cancer	2.44e-05	0.00142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.38e-05	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.37e-05	0.00138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PRKACA—adrenal gland cancer	2.31e-05	0.00135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MED12—adrenal gland cancer	2.15e-05	0.00125	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GNAS—adrenal gland cancer	1.98e-05	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDC42—adrenal gland cancer	1.96e-05	0.00114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCB1—adrenal gland cancer	1.94e-05	0.00113	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PRKACA—adrenal gland cancer	1.94e-05	0.00113	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.92e-05	0.00112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TERT—adrenal gland cancer	1.57e-05	0.000916	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GNAS—adrenal gland cancer	1.57e-05	0.000914	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PRKACA—adrenal gland cancer	1.57e-05	0.000912	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCB1—adrenal gland cancer	1.54e-05	0.000897	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.53e-05	0.000891	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BAD—adrenal gland cancer	1.37e-05	0.000797	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—POMC—adrenal gland cancer	1.33e-05	0.000775	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GNAS—adrenal gland cancer	1.27e-05	0.000739	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BRAF—adrenal gland cancer	1.25e-05	0.000725	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCB1—adrenal gland cancer	1.25e-05	0.000725	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—adrenal gland cancer	1.06e-05	0.000618	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—POMC—adrenal gland cancer	1.06e-05	0.000615	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—adrenal gland cancer	1e-05	0.000583	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CTNNB1—adrenal gland cancer	9e-06	0.000524	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—POMC—adrenal gland cancer	8.55e-06	0.000498	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—adrenal gland cancer	7.13e-06	0.000415	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—adrenal gland cancer	6.82e-06	0.000397	CbGpPWpGaD
